CLINICAL PROGRESSION INTRODUCTION METHOD CONCLUSION REFERENCES

Slides:



Advertisements
Similar presentations
TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
Advertisements

A Hematology Case Study about Leukemia by Sarah Wycoff
Introduction To Haematological Malignancies
LEUKEMIA—HEMATOLOGY {S1}
Histology for Pathology Hematopoietic Elements
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Rakesh Biswas MD Professor, Medicine, People's College of Medical Sciences, Bhopal, India Lecture first conceived and delivered to medicine undergrads.
LEUKEMIAS Dr Mehboob Khan Pathologist
WHO CLASSIFICATION OF MYELOID NEOPLASMS 2000  Chronic myeloproliferative disorders (CMPD)  Myelodysplastic / myeloproliferative diseases (MDS/MPD) 
Chapter 17 Chronic Leukemias.
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Chronic leukemias. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Chronic myeloid leukaemia. THE STORY OF CHRONIC MYELOID LEUKAEMIA ‘It is moreover, the same conclusion which Bennett came to in the much-discussed matter.
Marty O’Neill II Carmen Banea
CHRONIC MYELOID LEUKAEMIA Dr Rosline Hassan Department of Haematology School of Medical Sciences Universiti Sains Malaysia.
Tabuk University Faculty of Applied Medical Sciences
NYU Medicine Grand Rounds Clinical Vignette Maryann Kwa, MD PGY-2 January 12, 2011 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
HEMATOLOGY the branch of medicine devoted to the study of blood, blood-producing tissues, and diseases of the blood.
MLAB Hematology Keri Brophy-Martinez
C HRONIC LEUKEMIAS. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Chronic Leukemias. CMLCML CLLCLL CML A clonal disease results from an acquired genetic change in a pluri-potential hemopoietic stem cell within the BM.
Case Study MICR Hematology Spring, 2011 Case # 5 Hee Jin Kim, Hooman Nikizad and Arthur Omuro.
4th Year Medical Student KAU
Chronic myeloid leukaemia Cancer of granulocyte production Too many (non functioning) granulocytes are produced Bone marrow is overcrowded with ineffective.
Hematology and Hematologic Malignancies
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
CHRONIC LEUKEMIA Dr. Hayam Hebah Associate professor of Internal Medicine AL Maarefa College.
Heterogeneous group of hematopoietic neoplasms Uncontrolled proliferation and decreased apoptotic activity with variable degrees of differentiation Composed.
Leukaemias. Leukaemias: Malignant Disease of WBC Forming tissue or other hemopoietic elements: Lymphoblastic (ALL) Lymphoblastic (ALL)Acute Myeloid (AML)
Good morning… My presentation is about Calreticulin and PMF
..  Neoplastic proliferation of small mature appearing  lymphocytes and account 25% of leukemia  It is rare before 40 years of age, the median age.
Acute Leukemia Kristine Krafts, M.D..
Myeloproliferative disorder Clonal evolution Clonal evolution & stepwise progression to fibrosis, marrow failure or acute blast phase.
Case report Sudden blastic transformation in patient with chronic myeloid leukemia treated with imatinib mesylate Mehrdad Payandeh,MD Hematology, Medical.
Chronic leukemias أ. م. د. محمد شنين علي العبادي معاون عميد كلية الطب / جامعة كربلاء ورئيس فرع الامراض والطب العدلي M. B. Ch. B. & F. I. C. P.(Hematopathology)
LEUKEMIA Dr. Omar Alshaer. Acute Leukemia.
AML Clinical Presentation. Clinical Presentation: Symptoms Fatigue (50%) Anorexia and weight loss Fever with or without an identifiable infection (10%)
Case 316 Ryan Johnson, MD; Athena Cherry, PhD; Dita Gratzinger, MD, PhD Stanford University Medical Center SH-EAHP October 24, 2013.
CASE 411 Jose Gonzalez-Berjon, MD & Tariq Muzzafar, MD UT M.D. Anderson Cancer Center.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
Chronic Myelocytic Leukemia Mark D. Browning, M.D. Oncology/Hematology Associates February 26, 2016.
Chronic myeloid leukaemia
Associate professor of Internal Medicine
Acute Leukemia Kristine Krafts, M.D..
Blood Biochemistry BCH 577
CASE OF THE MONTH Dr Narender Tejwani Consultant ( Hematopathologist)
Malignancies of hematopoietic cells. Leukemia
LEUKEMIAS H.A. MWAKYOMA, MD.
Myeloproliferative disorder Clonal evolution Clonal evolution & stepwise progression to fibrosis, marrow failure or acute blast phase.
Department of Pathology
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
11 th lecture Chronic myeloid leukaemia By DR Fatehia Awny Faculty of Health Science Beirut Arab University
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC MYELOID LEUKEMIA (CML)
Associate professor of Internal Medicine
Leukemia Case 1.
Case Study ….
Chronic Leukemia Kristine Krafts, M.D..
Acute leukemia.
CASE STUDY Leukemia.
Diagnostic Hematology
Hairy cell Leukemia Case study.
Lymphoid Preponderance and the Absence of Basophilia
A presentation By Abedelaziz Taha Hammash supervisor \ Mr
Case study A 36-year-old woman presented with a two-month history of increasing fatigue and abdominal fullness with accompanying loss of appetite. There.
Neoplastic disorder.
Chronic Leukemia Dr. Noha Noufal.
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
Casual finding in the Laboratory of Chronic Myeloid Leukemia Falcones,K; Ortega,JJ; Ricart,E; Molina,R Hospital Virgen de los Lirios de Alcoy INTRODUCTION:
Presentation transcript:

CLINICAL PROGRESSION INTRODUCTION METHOD CONCLUSION REFERENCES Philadelphia Positive Chronic Myelogenous Leukemia in Pediatric Patients T Mukhopadhyay, R Awale, M Setia, R Maji , G Chhabra S Sharma, AK Mukhopadhyay Department of Laboratory Medicine All India Institute of Medical Sciences, New Delhi INTRODUCTION CLINICAL PROGRESSION Chronic Myelogenous Leukemia (CML) results from somatic mutation in hemopoeitic stem cells leading to clonal expansion and proliferation of granulocytic series. Incidence of CML in children is very rare, accounting for less than 3% of leukemia cases in children and adolescents. [1] Annual incidence: 1 per million in western world.[1] In India, age specific incidence rate of 0.04 per 100,000 was reported during 2001-2005. [2] Pediatric CML accounts for 10-15% of all CML, clinical presentation being similar to that of adults. Both cases were treated and put on follow up. Case 1 lost to follow up and presented after two years in blast crisis. Whereas case 2 improved. Clinical details, examination findings and laboratory investigations at follow up are tabulated in Table 2. TABLE 2: Case details Case 1 Case 2 Age/ Sex 8years / Female 15years/ Male Complaints of Low grade fever, increasing pallor X 2 days Cough X 3days left sided mass per abdomen increasing rapidly in size Asymptomatic On examination Pallor, periorbital puffiness Massive splenomegaly No pallor, lymphadenopathy or organomegaly Hemoglobin (gm %) 6.3 13.7 Total Leukocyte count (cells/cumm) 2,04,000 7,200 Differential Leukocyte count (%) Blast 28 - Promyelocyte Myelocyte 22 Metamyelocytes 3 Neutrophil 36 80 Lymphocytes 4 15 Monocyte 2 Eosinophil Basophils 1 NRBC (cells/100 WBC) Platelet count (cells/cumm) 2,14,000 1,30,000 Flowcytometry analysis cMPO+ , CD 34+, CD 134+, CD33+ , CD117+ , CD 45+ cCD 79a- , cCD3- , CD 19- cMPO+ , CD34+ , CD 45+ METHOD Patients presented to pediatric OPD in AIIMS with complaints of generalised weakness and mass in left hypochondrium. Complete blood count revealed leucocytosis. Diagnosis for CML was confirmed on the basis of morphology, cytochemistry, and molecular testing for the expression of BCR-ABL transcript fusion p210 by RT/PCR. Clinical details at presentation are tabulated in Table 1. SM Figure 1: Philadelphia chromosome  translocation t(9;22) occuring in CML. Figure 2: Per abdomen examination showing palpable enlarged spleen(SM). TABLE 1: Case details Case 1 Case 2 Age/ Sex 6years / Female 14years/ Male Complaints of Low grade fever, increasing pallor, left sided mass per abdomen X 4 months Low grade fever, left sided lump in abdomen X 2 months On examination Pallor Inguinal, axillary lymphadenopathy hepatosplenomegaly Splenomegaly Hemoglobin(gm %) 8.3 14.9 Total Leukocyte count (cells/cumm) 1,08,000 70,700 Differential Leukocyte count (%) Blast 1 Promyelocyte 4 - Myelocyte 15 Metamyelocytes 20 2 Neutrophil 39 80 Lymphocytes 6 8 Monocyte Eosinophil Basophils 5 3 NRBC (cells/100 WBC) Platelet count (cells/cumm) 2,60,000 2,68,000 Philadelphia chromosome (RT-PCR) POSITIVE Figure 5: Peripheral smear (400X) of CML in blast crisis in case 1. Figure 6: Peripheral smear (1000X) of case 1 showing Blast, Myelocyte, metamyelocyte. CONCLUSION One must have high sense of suspicion when leucocytosis is found even in pediatric age, as CML could be one of the differential diagnosis of leucocytosis. When differential count is also suggestive, should be followed up by molecular genetic analysis for presence of philadelphia chromosome in conjuction with bone marrow morphology and immunophenotyping. REFERENCES Rels et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program, 1975-1995. NIH pub no. 99-4649. Bethesda, MD: National Cancer Institute;1999. Au et al. Chronic Myeloid Leukemia in Aisa, Int J Hematol (2009) 89:14-23. WHO (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer: Lyon Figure 3: Leishman stained peripheral smear (400X) of case 1 showing showing marked leucocytosis and shift to left. Inset: MPO positivity on cytochemistry. Figure 4: Leishman stained peripheral smear (1000X) of case 2 showing features of CML in chronic phase.